当前位置: 首页 > 期刊 > 《中国全科医学》 > 2025年第14期
编号:2395628
2024年V4版《NCCN结肠癌临床实践指南》更新解读
http://www.100md.com 2025年8月25日 中国全科医学 2025年第14期
    

    【中图分类号】R735.35【文献标识码】A DOI:10.12114/j.issn.1007-9572.2024.0379

    Interpretation of the Updated NCCN Clinical Practice Guidelines for Colon Cancer(2024.V4)

    UniversityofTraditional ChineseMedicineChina *Corresponding author:CHEN Min,Deputy chief physician ofTCM;E-mail:cm@cdutcm.edu.cn

    【Abstract】The 2024.V4of the NCCN Clinical Practice Guidelines forColon Cancer provides important updates on pathologicaltestingofsystemictherapyforcoloncancer,doseofhemoradiotherapy,andtreatmentandmanagementofmetastatic coloncancer.Firstly,theguidelines emphasizetheimportanceof genomictestinginthesystemic treatmentofmetastaticcolon cancer.Secondly,thedoseofchemoradiotherapyandtargetedtherapeutictargetsoflocallyadvancedcoloncancerweremodified. Finall,thenewdrugrepitinibforthesecond-linetreatmentofmetastaticcoloncancerprovidesanewoptionforpatientswith positiveneurotrophic tyrosinereceptorkinase(NTRK)genefusion.Intermsofpatientmanagement ......

您现在查看是摘要页,全文长 18349 字符